Sara Ashlee Barker and 2 other WNBA prospects drafted higher than expected

NEW YORK CITY — Ahead of the 2025 WNBA Draft, most expected Paige Bueckers, Dominique Malonga, and Sonia Citron to round out the top three picks. But, after that, mock drafts conflicted. ESPN’s latest mock draft projected that USC forward Kiki Iriafen, LSU forward Aneesah Morrow, and Maryland point guard Shyanne Sellers would be selected…

3 Cebu grads are topnotchers

Stock Photo CEBU CITY, Philippines — Three graduates from Cebu-based universities landed in the top 10 passers of the March 2025 Physicians Licensure Examinations, results of which came out on April 14, 2025. Adrian Eleazar Go from the Cebu Institute of Medicine (CIM) topped the list after scoring 87.75 percent. Angel Anne Dugaduga Ambayan from…

George Foreman, boxing legend, remembered for his love of family

(FILES) Referee Joe Cortez (R) holds George Foreman’s arm up in victory after Foreman knocked Michael Moorer out in the tenth round of their scheduled 12 round IBF/WBA heavyweight title fight, on November 5, 1994 in Las Vegas, Nevada. Former heavyweight boxing champion George Foreman, who fought an iconic battle with Muhammad Ali before later…

Minnesota Lynx acquire sharpshooting veteran in latest WNBA trade

The Minnesota Lynx have traded their first-round pick in the 2026 WNBA Draft in exchange for Washington Mystics forward Karlie Samuelson. Samuelson is fresh off a career season with the Mystics in which she averaged 8.4 points per game and shot 39.8% from three, also posting 2.6 rebounds and 2.1 assists per game. In 2023,…

Pfizer ends development of potential pill obesity treatment

Pfizer signage is displayed at the Pfizer NYC Headquarters in New York. The company is ending the development of its potential pill obesity treatment. (AP Photo/Yuki Iwamura) UNITED STATES – Pfizer is ending the development of its potential once-daily pill treatment for obesity after venturing into the biggest and most expensive level of clinical testing….

Pfizer ends development of potential pill obesity treatment

Pfizer signage is displayed at the Pfizer NYC Headquarters in New York. The company is ending the development of its potential pill obesity treatment. (AP Photo/Yuki Iwamura) UNITED STATES – Pfizer is ending the development of its potential once-daily pill treatment for obesity after venturing into the biggest and most expensive level of clinical testing….